Gemcitabin-Teva 200 mg, Pulver zur Herstellung einer Infusionslösung
7680592000041
CH-59200
L01BC05
07.16.1.
1 / 3
google
Details
- Product number
- 5920001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: gemcitabinum 200 mg ut gemcitabini hydrochloridum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, pro vitro corresp. natrium 3.5 mg.
Articles (1)
Gemcitabin-Teva 200 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
3.5 MG | Substance | HBESI |
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 59200
- Drug name
- Gemcitabin-Teva, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- L01BC05
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 09/06/2009
- Authorization expiration date
- 01/07/2025
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GEMCITABIN Teva subst sèche 200 mg flac
- Description (DE)
- GEMCITABIN Teva Trockensub 200 mg Durchstf
- Market withdrawal
- 01/07/2025
- Narcotic (BTM)
- No
Available generics
Gemcitabin Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680652880019
CHF 33.90
Gemcitabin Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680652880026
CHF 103.00
Gemcitabin Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680652880033
CHF 188.10
Gemcitabin-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680650050049
CHF 37.60